Form 4: Exponent CFO Granted 19,000 Stock Options

Exponent Inc.'s EVP & CFO, Richard L. Schlenker Jr., was granted 19,000 stock options at an exercise price of $70.16, vesting over four years.

Summary

• Richard L. Schlenker Jr., Executive Vice President and Chief Financial Officer of Exponent Inc. (EXPO), was granted 19,000 stock options.
• The grant includes 1,425 Incentive Stock Options and 17,575 Non-Qualified Stock Options.
• The exercise price for all granted options is $70.16 per share.
• The transaction date for these option grants was February 20, 2026.
• These options will become exercisable in four equal annual installments.
• The expiration date for both types of options is February 20, 2036.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting standard executive compensation practices designed to align management incentives with shareholder interests, though it introduces potential future dilution.

Positives

• The grant of stock options aligns the executive's long-term financial interests with those of the shareholders, incentivizing company performance.
• This compensation structure is a common method to attract and retain key management personnel.

Negatives

• The future exercise of these options could lead to a slight dilution of existing shareholder value.

Risks

• The options will only have value if Exponent Inc.'s stock price rises above the exercise price of $70.16 per share.
• Potential future dilution of existing shareholder equity upon the exercise of these options.

Future Outlook

Not applicable as this filing primarily reports an executive's stock option grant, not forward-looking company performance or financial guidance.

Industry Context

StockSavvy.ai notes that executive stock option grants are a common component of compensation packages across various industries, particularly in professional services and consulting firms like Exponent, aiming to incentivize long-term performance and retention.

Stakeholder Impact

• Shareholders: Potential for future dilution if options are exercised, but also potential for increased executive motivation leading to better company performance.
• Executive (Richard L. Schlenker Jr.): Receives a significant equity incentive, aligning personal wealth with company stock performance and retention.

Next Steps

• The granted options will vest in four equal annual installments, allowing the executive to exercise them progressively.
• The executive may choose to exercise the vested options at any time before their expiration date of February 20, 2036.

Key Dates

Keywords

Exponent Inc., EXPO, Stock Options, Insider Transaction, CFO, Executive Compensation, Form 4, Equity Grant